This page lists all pharmaceutical reports related to the field of Immunology & Inflammatory Diseases. The reports include market research reports and pipeline analyses.
- The World Market for Prescription Respiratory Drugs
- The World Market for Prescription Orthopedic Drugs
- Psoriasis and Psoriatic Arthritis: A Strategic Analysis of the Market in the United States
- Womens Health: Worldwide Prescription Drug Markets
- The World Market for Prescription Gastrointestinal Drugs
- The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products
- The Worldwide Market for Prescription Dermatological Drugs
- Drug Delivery Markets: Pulmonary Delivery Systems
- Pain Therapeutics - Drugs, Markets and Companies
- Personalized Medicine - scientific and commercial aspects
- Nitric Oxide - Therapeutics, Markets and Companies
- The World Allergy Market 2006-2011: The Rx-OTC Rush
- Therapeutic Monoclonal Antibodies, 2006-2011
- The Inflammatory Bowel Disease Market Outlook to 2012
- The Global Rheumatoid Arthritis Market Forecasts to 2012
- Disease Modification in Rheumatoid Arthritis - Competition for the anti-TNF failure
- Stakeholder Opinions: Asthma Phenotypes – A changing paradigm
- Pipeline Insight: Multiple Sclerosis - The oral revolution
- Atopic Dermatitis - Unmet needs and market opportunities
- Early Toxicology: Markets and Approaches
- Multiple Sclerosis World Market Outlook to 2011
- Psoriasis - Anti-TNF's lead another indication
- Osteoarthritis - Market sees steady growth
- Multiple Sclerosis - Disease-modifying efficacy and side effects guide treatment
- Inflammatory Bowel Disease-Competition Increases for the Biologics
- Osteoarthritis - The Wait for a DMOAD Continues
- Pipeline Insight: Asthma/COPD - Targeted therapies on the horizon
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Rheumatoid Arthritis - Biologics battle up the treatment algorithm
- Commercial Insight: Asthma/COPD - ICS/LABA combinations continue to dominate
- From Blockbuster to Nichebuster
- Commercial Insight: Transplantation
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biotech in Autoimmune and Inflammatory Disease 2006
- Biogenerics
- Osteoarthritis - Preconceptions Damage Awareness and Treatments
- Sepsis - Under reaction to an overreaction
- Monoclonal Antibodies in Asthma
- Inhalable Drug Delivery
- Therapeutic Vaccines
- COPD
- Disease Modification in Rheumatoid Arthritis - The Biologics Boom
- Juvenile Arthritis - A Niche In The Market
- Asthma and COPD - Get SMART
- Gastrointestinal Disorders Market Intelligence to 2012
- Biogenerics 2005: A New Level of Complexity
- Pipeline Insight: Disease Modification In Rheumatoid Arthritis
- Idiopathic Pulmonary Fibrosis - A New Hope
- Monoclonal Antibody Therapies: Evolving into a $30 billion market
- Pipeline Insight Asthma/COPD/Allergic Rhinitis - As Patents Expire, Novel Combinations Inspire
- Psoriasis - Biologics Impact Treatment Regimes Across the Globe
- Stakeholder Insight: Asthma - Combination Therapy Appropriate for Everyone?
- Systemic Lupus Erythematosus - On the Verge of a Breakthough
- Immunotherapy in Allergic Rhinitis
- Kidney Transplantation - Switching to calcineurin inhibitor-free immunosuppression
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Multiple Sclerosis - Continued growth makes the MS market a highly attractive investment
- Drug Discovery Tools for High-Content Analysis
- Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential
- ALLERGY - Therapy Area Pipeline Report
- ARTHRITIS - Therapy Area Pipeline Report
- AUTOIMMUNE DISEASES - Therapy Area Pipeline Report
- CROHN DISEASE - Therapy Area Pipeline Report
- INFLAMMATION - Therapy Area Pipeline Report
- LUPUS - Therapy Area Pipeline Report
- RHEUMATOID ARTHRITIS - Therapy Area Pipeline Report
- ORGAN TRANSPLANTATION - Therapy Area Pipeline Report
- MULTIPLE SCLEROSIS - Therapy Area Pipeline Report
- ECZEMA - Therapy Area Pipeline Report
- ULCERATIVE COLITIS - Therapy Area Pipeline Report
- TYPE 1 DIABETES - Therapy Area Pipeline Report
- OSTEOARTHRITIS - Therapy Area Pipeline Report
- OCULAR INFLAMMATION - Therapy Area Pipeline Report
- ASTHMA - Therapy Area Pipeline Report
- BRONCHITIS - Therapy Area Pipeline Report
- BRONCHOSPASM - Therapy Area Pipeline Report
- CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Therapy Area Pipeline Report
- COUGH - Therapy Area Pipeline Report
- NASAL CONGESTION - Therapy Area Pipeline Report
- GINGIVITIS and PERIODONTITIS - Therapy Area Pipeline Report
- Autoimmune Market Outlook to 2012
- Monoclonal Antibodies: strategic analysis of the mAb market out to 2012
- The Future of Biosimilars: Key opportunities & emerging therapies
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Commercial and Pipeline Insight: Allergic Rhinitis
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Immunomodulators: Therapeutic Needs, Pipelines and Prospects
- Translational Medicine in Biopharmaceutical Research and Development
- Multiple Sclerosis Market Analysis and Forecasts Report 2007-2022
- The Gastrointestinal Market Outlook to 2012
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pediatric Drugs - the Worldwide Market
- Autoimmune Disorders and Transplant Rejection - The Potential of T-cells Targeted Therapeutics
- Rheumatoid arthritis - Emerging drug discovery targets and therapeutic candidates
- Asthma Therapeutics - New treatment options and emerging drug discovery targets
- BAFF (BLys) and APRIL: Emerging Targets for autoimmune disease & Cancer Therapeutics
- Coxibs - Past Problems and Future Potential
- Disease Modifying Osteoarthritis Drugs - The Search for the Holy Grail Continues
- Tysabri - Can Efficacy of VLA-4 Mechanism Overcome Safety Concerns?
- Commercial Insight: Asthma and COPD
- Stakeholder Insight: Osteoarthritis - COX-2s wear down traditional NSAID use
- Stakeholder Insight: Rheumatoid Arthritis - DMARDs Gain Ground as Biologics Competition Intensifies
- Commercial and Stakeholder Perspectives: Allergic Rhinitis - Is There Life After Claritin?
- Commercial and Pipeline Perspectives: Lower GI Disorders - Remicade Leads Growth as Novel Biologics
- Commercial and Pipeline Perspectives: Rheumatoid Arthritis - Novel Biologics Drive Innovation
- Commercial Perspectives: Multiple Sclerosis - How to Find Opportunities in an Unremitting Market
- Inflammatory Bowel Disease - Efficacy and Compliance Key to Maximizing Patient Share
- Pipeline Insight: Asthma, COPD and Allergic Rhinitis - Weak Late Stage Pipeline Leaves Innovation to
- The Future of Monoclonal Antibody Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
- The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets
- Women's Health: Worldwide Prescription Drug Markets - 3rd Edition
- Rheumatoid Arthritis: The 45+ Market in the United States for Drugs and Biologics
- The Worldwide Market for Prescription Dermatological Drugs - 4th Edition
- Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline
- Gene Expression Profiling Markets
- Organ Transplant Immunosuppressive Markets
- The World Dermatological Market Analysis & Forecasts 2007-2022
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Inflammatory Bowel Disease - Debate over early aggressive treatment continues
- How to Conduct Clinical Trials in China
- Prescription Dermatological Drugs: Worldwide Market
- Worldwide Market for Rheumatoid Arthritis and Lupus Treatments
- Alpha 1 Antitrypsin Deficiency
- Commercial Insight: Autoimmune Diseases - Market continues to prosper
- Launching Combination Products: Brand extension and franchise development strategies
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
- Systemic Lupus Erythematosus - Market set to enter era of biologic therapies
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Portable Inhaler Devices - Current Market and Life Cycle Opportunities
